Logo

07- CV Jean-Sébastien Hulot

Jean-Sebastien Hulot

PUPH
TEAM LEADER – CELLULAR, MOLECULAR AND PHYSIOLOGICAL MECHANISMS OF HEART FAILURE
Mail : jean-sebastien.hulot@inserm.fr


back to Research Team


ORCID


Twitter


Linkedin

SCIENTIFIC TOPICS

Heart Failure 

Induced pluripotent stem cells

Organoids

Myocardial relaxation

Fibrosis

Pharmacology

ITMO

Course and current status

Dr Jean-Sébastien Hulot is Professor of Medicine,
Pharmacology at Université de PARIS Cité, France. He is leading a team at Paris
Cardiovascular Research Center since 2019 and is Director of the Clinical
Investigations Center at the Hôpital Européen Georges Pompidou, Paris
Hospitals.

He is a medical cardiologist and received his MD
degree at Paris University Hospitals and his PhD degree in clinical and
experimental pharmacology at the René Descartes Paris 5 University. From 2010
to 2014, he served as an Associate Professor of Medicine, Cardiology at the
Cardiovascular Research Center at Mount Sinai School of Medicine in New York,
USA.

Academic position

2021-           Coordinator, Research Federation Prevent_Heart Failure, Inserm / APHP / Université de Paris ; website

2018-           Team leader « Cellular, molecular and physiological mechanisms of heart failure », PARIS Cardiovascular Research Center, PARCC, INSERM UMR970, Paris

2018-            Professor of medicine, Director Clinical Investigations Center, CIC-P 1418, Hôpital Européen Georges Pompidou, Paris

2013-2018   Professor of medicine, Institut Hospitalo-Universtaire ICAN (Institut de CardioMétabolisme et Nutrition ICAN), Pitié-Salpêtrière hospital, Paris

2010-2013    Associate Professor of Medicine, Cardiovascular Research Center, Director Pharmacogenomics & Personalized therapeutics, Mount Sinai School of Medicine, New York

Major responsabilities (past 10 years)

2019-now        Associate Editor, Journal of American College of Cardiology (IF: 27.203)

2020-22          President-elect, Groupe de Réflexion sur la Recherche Cardiovasculaire (G.R.R.C.), French Society of Cardiology

2022-now        Member of the Pharmacology&Pharmacotherapy Committee, Heart Failure Association, ESC

2018-now        Member of the HFmrEF/HFpEF Committee, Heart Failure Association, ESC

2017-2019       Member, AVIESAN, Working group on the development of human-based organoïds for preclinical testing

2016-20           Member-elect, Nucleus of the Working Group on Cellular Biology of the heart, ESC

2016-20           Member of the Translational Research Committee, Heart Failure Association, ESC

Awards

2008                 Jeffrey Isner Award, Cardiovascular Cell Gene Therapy, New York

2012                 Grand Prix Robert Debré, Recherche Médicale

2014                 Fellow of the American Heart Association, Functional Genomics and translational biology Council

2015                 Fellow of the European Society of Cardiology

2019-now         Prize of Scientific Excellence